Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV

Digestive Diseases and Sciences

Volumn 62, Issue 1, 2017, Pages 76-83

  Natarajan, Yamini ^a   White, Donna L ^a,b,c   El Serag, Hashem B ^a,b,c   Ramsey, David ^a   Richardson, Peter ^a   Kuzniarek, Jill ^a   Shukla, Richa ^a   Tansel, Aylin ^a   Kanwal, Fasiha ^a,b,c  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b EAST TEXAS MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Comorbidity; Epidemiology; Hepatitis C; Hepatology; Mortality; Natural history; Prognosis

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; COMORBIDITY ASSESSMENT; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; HEPATITIS C; HUMAN; HYPERTENSION; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME VARIABLE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL; AGE; CAUSE OF DEATH; DAILY LIFE ACTIVITY; DRINKING BEHAVIOR; END STAGE LIVER DISEASE; HEALTH STATUS; HEART FAILURE; HEPATITIS C, CHRONIC; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; SMOKING; SURVIVAL RATE; UNITED STATES;

ACTIVITIES OF DAILY LIVING; AGE FACTORS; ALCOHOL DRINKING; CAUSE OF DEATH; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; END STAGE LIVER DISEASE; FEMALE; HEALTH STATUS; HEART FAILURE; HEPATITIS C, CHRONIC; HUMANS; HYPERTENSION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SMOKING; SURVIVAL RATE; UNITED STATES;

EID: 84988632624     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-016-4303-2     Document Type: Article

References (21)

1. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341:556–562.
2. Tetsche MS, Dethlefsen C, Pedersen L, Sorensen HT, Norgaard M. The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study. BMC Cancer. 2008;8:31.
3. Fried LP, Kronmal RA, Newman AB, et al. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA. 1998;279:585–592.
4. Carey EC, Walter LC, Lindquist K, Covinsky KE. Development and validation of a functional morbidity index to predict mortality in community-dwelling elders. J Gen Intern Med. 2004;19:1027–1033.
5. Saliba D, Elliott M, Rubenstein LZ, et al. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc. 2001;49:1691–1699.
6. Eng JA, Clough-Gorr K, Cabral HJ, Silliman RA. Predicting 5- and 10-year survival in older women with early-stage breast cancer: self-rated health and walking ability. J Am Geriatr Soc. 2015;63:757–762.
7. Szabo SM, Samp JC, Walker DR, et al. Liver-specific case fatality due to chronic hepatitis C virus infection: a systematic review. Ann Hepatol. 2015;14:618–630.
8. Guiltinan AM, Kaidarova Z, Custer B, et al. Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors. Am J Epidemiol. 2008;167:743–750.
9. Duberg A-S, Törner A, Davidsdóttir L, et al. Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study. J Viral Hepat. 2008;15:538–550.
10. Lee M-H, Yang H-I, Lu S-N, et al. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis. 2012;206:469–477.
11. Omland LH, Jepsen P, Krarup H, et al. Increased mortality among persons infected with hepatitis C virus. Clin Gastroenterol Hepatol. 2011;9:71–78.
12. White DL, Tavakoli-Tabasi S, Kuzniarek J, Pascua R, Ramsey DJ, El-Serag HB. Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males. Hepatology. 2012;55:759–768.
13. Sohn M-W, Arnold N, Maynard C, Hynes DM. Accuracy and completeness of mortality data in the Department of Veterans Affairs. Popul Health Metr. 2006;4:2.
14. Schonberg MA, Davis RB, McCarthy EP, Marcantonio ER. Index to predict 5-year mortality of community-dwelling adults aged 65 and older using data from the National Health Interview Survey. J Gen Intern Med. 2009;24:1115–1122.
15. Schonberg MA, Davis RB, McCarthy EP, Marcantonio ER. External validation of an index to predict up to 9-year mortality of community-dwelling adults aged 65 and older. J Am Geriatr Soc. 2011;59:1444–1451.
16. Drazer MW, Prasad SM, Huo D, et al. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making. Cancer. 2014;120:1491–1498.
17. 13th Annual meeting of the society for the study of reproduction. Portland, Oregon, August 2–5, 1997. Abstracts. Biol Reprod. 1997;56:83–243.
18. Kerr KF, Wang Z, Janes H, McClelland RL, Psaty BM, Pepe MS. Net reclassification indices for evaluating risk prediction instruments: a critical review. Epidemiology. 2014;25:114–121.
19. Bernacki REBS. Communication about serious illness care goals a review and synthesis of best practices. JAMA. 2014;174:1994–2003.
20. Jepsen P, Vilstrup H, Lash TL. Development and validation of a comorbidity scoring system for patients with cirrhosis. Gastroenterology. 2014;146:147–156. (quiz e15–e16).
21. Sharabiani MTA, Aylin P, Bottle A. Systematic review of comorbidity indices for administrative data. Med Care. 2012;50:1109–1118.